World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
103
Citations
41398
World Ranking
637
National Ranking
372

Medicine

D-Index
103
Citations
41745
World Ranking
7322
National Ranking
3832

Overview

Myron J. Levin is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research predominantly lies within the field of Medicine, with a particular focus on Epidemiology and Infectious Diseases. Additional subfields of interest include Health, Dermatology, and Genetics.

The main topics covered in their work include:

  • Herpesvirus Infections and Treatments
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • Respiratory viral infections research
  • Cytomegalovirus and herpesvirus research
  • Dermatology and Skin Diseases

Levin has contributed to multiple recent publications, some of which are:

  • "Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials," 2020, Lara D. Veeken
  • "Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals," 2020, Journal of the American Geriatrics Society
  • "Vaccines for older adults," 2021, BMJ
  • "LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults," 2021, Open Forum Infectious Diseases
  • "AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019," 2022, Clinical Infectious Diseases

Their frequent collaborators include:

  • Adriana Weinberg
  • Michael Johnson
  • Maarten J. Postma
  • Andrew Ustianowski
  • Katie Streicher

Levin's work is often published in the following venues:

  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • UNC Libraries
  • Human Vaccines & Immunotherapeutics
  • Vaccines

Best Publications

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

    Lorry G. Rubin;Myron J. Levin;Per Ljungman;E. Graham Davies

  • Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

    Himal Lal;Anthony L. Cunningham;Olivier Godeaux;Roman Chlibek

  • Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

    A. L. Cunningham;H. Lal;M. Kovac;R. Chlibek

  • Recommendations for the management of herpes zoster.

    Robert H. Dworkin;Robert W. Johnson;Judith Breuer;John W. Gnann;John W. Gnann

  • Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

    Lorry G. Rubin;Myron J. Levin;Per Ljungman;Per Ljungman;E. Graham Davies

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy

    Teresa H. Bacon;Myron J. Levin;Jeffry J. Leary;Robert T. Sarisky

  • Efficacy Results of a Trial of a Herpes Simplex Vaccine

    Robert B. Belshe;Peter A. Leone;David I. Bernstein;Anna Wald

  • Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

    Mark H. Einstein;Mira Baron;Myron J. Levin;Archana Chatterjee

  • Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years

    Kenneth E. Schmader;Myron J. Levin;John W. Gnann;John W. Gnann;Shelly A. McNeil

  • The rationale for quadrivalent influenza vaccines

    Christopher S. Ambrose;Myron J. Levin

  • Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with Acyclovir

    Clyde S. Crumpacker;Lowell E. Schnipper;Steven I. Marlowe;Patricia N. Kowalsky

  • Varicella-Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

    M. J Levin;M. N Oxman;J. H Zhang;G. R Johnson

  • Decline in Varicella-Zoster Virus (VZV)–Specific Cell-Mediated Immunity with Increasing Age and Boosting with a High-Dose VZV Vaccine

    Myron J. Levin;Jeffrey G. Smith;Robin M. Kaufhold;Debra Barber

  • Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults.

    Jason C Cole;Sarosh J Motivala;Daniel J Buysse;Michael N Oxman

  • Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women

    David I. Bernstein;Abbie R. Bellamy;Edward W. Hook;Myron J. Levin

  • Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

    Clyde S. Crumpacker;Lowell E. Schnipper;John A. Zaia;Myron J. Levin

  • Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

    Anne A. Gershon;Michael D. Gershon;Judith Breuer;Myron J. Levin

  • Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.

    Paul M. Coplan;Paul M. Coplan;Kenneth Schmader;Alexander Nikas;Ivan S.F. Chan

  • The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

    Mélanie Drolet;Marc Brisson;Kenneth E. Schmader;Myron J. Levin

  • Varicella-Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

    Adriana Weinberg;Jane H. Zhang;Michael N. Oxman;Gary R. Johnson

  • Airborne Transmission of Chickenpox in a Hospital

    Jeanne M. Leclair;John A. Zaia;Myron J. Levin;Richard G. Congdon

  • Prevention of Cytomegalovirus Infection by Cytomegalovirus Immune Globulin After Marrow Transplantation

    J D Meyers;J Leszczynski;J A Zaia;N Flournoy

Frequent Co-Authors

Adriana Weinberg
Adriana Weinberg University of Colorado Anschutz Medical Campus
Michael N. Oxman
Michael N. Oxman University of California, San Diego
Kenneth E. Schmader
Kenneth E. Schmader Duke University
Anthony R. Hayward
Anthony R. Hayward Brown University
Anthony L. Cunningham
Anthony L. Cunningham University of Sydney
Anne A. Gershon
Anne A. Gershon Columbia University
Shelly A. McNeil
Shelly A. McNeil Dalhousie University
Michael R. Irwin
Michael R. Irwin University of California, Los Angeles
Janet E. McElhaney
Janet E. McElhaney Health Sciences North
Clyde S. Crumpacker
Clyde S. Crumpacker Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to diverse healthcare careers, many of which can be enhanced through specialized nursing programs. For example, pursuing the cheapest psych np programs can provide an affordable pathway for those interested in combining immunology with mental health care.

Understanding potential earnings is crucial when selecting a career path. The dnp salary data helps students and professionals evaluate financial prospects across various states, aiding informed decisions about where to study and work.

For nursing professionals, career advancement is always a priority. Transitioning to specialized roles is made easier through programs like the fnp to acute care np bridge program, which supports nurse practitioners moving into acute care — a field closely linked with immunology and critical care.

Additionally, enrolling in an accelerated nurse practitioner program enables motivated students to fast-track their nursing careers, gaining essential skills that complement their immunology background.

Best Scientists Citing Myron J. Levin

Trending Scientists

Recently Published Articles